Role of an anti-epidermal growth factor receptor in treating cancer.
about
EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximabIndividualized treatment of gastric cancer: Impact of molecular biology and pathohistological featuresChlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancerSimultaneous blockade of both the epidermal growth factor receptor and the insulin-like growth factor receptor signaling pathways in cancer cells with a fully human recombinant bispecific antibody.Phase II trial of cetuximab and carboplatin in relapsed platinum-sensitive ovarian cancer and evaluation of epidermal growth factor receptor expression: a Gynecologic Oncology Group study.Cetuximab as second-line therapy in patients with metastatic esophageal adenocarcinoma: a phase II Southwest Oncology Group Study (S0415)Immunotherapy of cancer by active vaccination: does allogeneic bone marrow transplantation after non-myeloablative conditioning provide a new option?Innovative Therapies against Human Glioblastoma MultiformeNovel chemotherapeutic and targeted agents in metastatic colorectal cancer: the time has arrived.Anti-EGFR-Conjugated Hollow Gold Nanospheres Enhance Radiocytotoxic Targeting of Cervical Cancer at Megavoltage Radiation EnergiesImmunotherapeutic strategies for malignant glioma.Monoclonal antibodies for brain tumour treatment.Therapeutic potential of EGFR-related protein, a universal EGFR family antagonist.Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinoma.A constitutively active form of neurokinin 1 receptor and neurokinin 1 receptor-mediated apoptosis in glioblastomasBiology of human cutaneous melanomaTargeting epidermal growth factor receptor in the treatment of non-small-cell lung cancer.Immunotoxins and other conjugates containing saporin-s6 for cancer therapy.Monoclonal antibodies for treating gastric cancer: promises and pitfalls.Expressions and clinical significance of COX-2, VEGF-C, and EFGR in endometrial carcinoma.Imaging epidermal growth factor receptor phosphorylation in human colorectal cancer cells and human tissues.A fully human recombinant IgG-like bispecific antibody to both the epidermal growth factor receptor and the insulin-like growth factor receptor for enhanced antitumor activity.Akt, MAPK (Erk1/2), and p38 act in concert to promote apoptosis in response to ErbB receptor family inhibition.Cetuximab in metastatic or recurrent head and neck cancer: the EXTREME trial.Genomic compartmentalization of gene families encoding core components of metazoan signaling systems.Abnormal expression of epidermal growth factor and its receptor in the forebrain and serum of schizophrenic patients.
P2860
Q24652337-05374E5A-88A6-4B1F-8334-C11A362768E9Q26776198-4D99C67B-180A-46C5-B086-3AAA62E18DBAQ28214310-D8F3D6EE-29C3-458E-9D19-7BCC45873AE0Q28362939-9A5734EB-BCA9-467B-9CBB-C518987347C0Q31016741-6EF934C1-E703-401C-A2A1-0D32CBCE58FCQ33378256-31BCFE9C-9105-4ACC-9E49-5808F71010E1Q34084724-75B33ED3-A2EB-4E3C-AE6A-DDBD952CB2FAQ35142329-FFC2C456-F2F2-42BE-975D-8FAAFA9B5DA1Q35374492-36F7FAAC-DBB5-426F-897E-A974CAFE05B5Q35594038-293C5B81-1D71-4B4E-ABFE-16715B8AC230Q35625307-C21482F6-0F5C-4D03-9519-C60116CE4DD3Q35778576-168FF17A-A918-403A-A93D-EA5126F89568Q35873775-A5A31900-2E2E-43A8-A638-C71173B27B9AQ36429446-E80CE23B-53B6-4768-880B-2B21C043587DQ36623214-8C96CC8F-976C-4C27-AC62-190D69CC6379Q37226704-F09448C5-C170-4D0A-8517-5DF800BC1D6BQ37307195-341E7ECE-147C-4931-9517-DFED997CA8E8Q37768460-A9C628A1-7171-4186-9D05-13789FB445AEQ37954336-8F56280B-A315-4654-B16B-17635ADC2DDAQ38772049-1D960769-43C3-4C0D-87A7-652839073128Q38803042-E1A824D1-F667-417F-A33C-707D427D4D86Q40419074-2FAB02BE-079A-4DE9-8715-907FAA8445EEQ40448458-D25DBAF1-D17C-480B-8F11-BF6E911DDA13Q42501963-E8E468C1-41BD-45C3-854F-FBAC547C28D6Q43261590-2A8C162A-7D17-40DA-8709-A59C5C3633C0Q44255021-543B524D-231B-4A6D-BF31-800E823160CAQ48502505-5FD5BD92-5FAC-472B-B0D7-D1F7713AD932
P2860
Role of an anti-epidermal growth factor receptor in treating cancer.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Role of an anti-epidermal growth factor receptor in treating cancer.
@ast
Role of an anti-epidermal growth factor receptor in treating cancer.
@en
type
label
Role of an anti-epidermal growth factor receptor in treating cancer.
@ast
Role of an anti-epidermal growth factor receptor in treating cancer.
@en
prefLabel
Role of an anti-epidermal growth factor receptor in treating cancer.
@ast
Role of an anti-epidermal growth factor receptor in treating cancer.
@en
P356
P1476
Role of an anti-epidermal growth factor receptor in treating cancer.
@en
P2093
H W Waksal
P2888
P304
P356
10.1023/A:1006302101468
P577
1999-01-01T00:00:00Z
P6179
1044207307